ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

ATRA Atara Biotherapeutics Inc

0.657
-0.0275 (-4.02%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Atara Biotherapeutics Inc ATRA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0275 -4.02% 0.657 09:00:00
개장가 저가 고가 종가 전일 종가
0.70 0.61 0.7062 0.6503 0.6845
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/04/202405:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
28/03/202421:30BWAtara Biotherapeutics Announces Fourth Quarter and Full Year..
07/03/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202410:21EDGAR2Form 144 - Report of proposed sale of securities
05/03/202410:19EDGAR2Form 144 - Report of proposed sale of securities
05/03/202410:18EDGAR2Form 144 - Report of proposed sale of securities
05/03/202410:17EDGAR2Form 144 - Report of proposed sale of securities
29/02/202423:05BWAtara Biotherapeutics Receives FDA Clearance of IND..
29/02/202406:30BWAtara Biotherapeutics to Participate in Cell Therapy Panel..
24/02/202406:30EDGAR2Form 8-K - Current report
14/02/202423:00BWAtara Biotherapeutics Announces Submission of..
01/02/202416:25PRNUSAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
01/02/202408:30BWAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
10/01/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/01/202406:01EDGAR2Form 8-K - Current report
08/01/202423:00BWAtara Biotherapeutics Announces $15 Million Registered..
08/01/202422:11EDGAR2Form 8-K - Current report
08/01/202422:00BWAtara Biotherapeutics to Present Recent Progress and Key..
05/01/202406:01BWAtara Biotherapeutics to Present at the 42nd Annual J.P...
04/01/202406:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/12/202306:30EDGAR2Form 8-K - Current report
21/12/202306:01BWAtara Biotherapeutics Announces Closing of Expanded Global..
12/12/202302:00BWAtara Biotherapeutics Presents Positive Preclinical Data on..
02/12/202306:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
30/11/202308:05BWAtara Biotherapeutics To Present Positive New Tab-cel®..
23/11/202306:01BWAtara Biotherapeutics to Participate at the 6th Annual..
21/11/202307:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202307:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202307:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202307:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202306:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
11/11/202306:01BWAtara Biotherapeutics To Participate at the Stifel..
09/11/202307:35BWAtara Biotherapeutics Announces Primary Analysis Data from..
02/11/202306:25EDGAR2Form S-3 - Registration statement under Securities Act of..
02/11/202305:05EDGAR2Form 8-K - Current report
01/11/202321:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:35EDGAR2Form 8-K - Current report
01/11/202321:30BWAtara Biotherapeutics Announces Expanded Global Tab-cel®..
07/10/202305:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
20/09/202305:50DJNAtara Biotherapeutics to Submit New FDA Biologics License..
20/09/202305:01BWAtara Biotherapeutics Announces Plans to Submit Tab-cel® BLA..

최근 히스토리

Delayed Upgrade Clock